Abstracts (HTML) List of Authors

Abada, P

Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies

Abreu, MT

Efficacy and Safety of Ustekinumab as Maintenance Therapy in Ulcerative Colitis: Week 44 Results from UNIFI

Adolph, T

Western-diet-derived arachidonic acid induces epithelial ferroptosis which is a feature of Crohn's disease
Polyunsaturated fatty acids fuel intestinal inflammation in GPX4 deficient hosts
Alpha 1 antitrypsin ameliorates experimental alcoholic liver disease and determines patient outcome

Adolph, TE

Lipid peroxidation of polyunsaturated fatty acids triggers a pro-inflammatory cytokine response in intestinal epithelial cells
Crohn's disease (CD) derived intestinal organoids as a model to study inflammation emanating from the intestinal epithelium

Aigner, E

Biochemical liver tests reflect the genetic risk for fatty liver with increasing body weight but not with alcohol consumption
AMA-positives without PBC and healthy subjects have similar bile acid profiles but are different from PBC patients
Experience with obeticholic acid in patients with primary biliary cholangitis – multicentric Austrian analysis

Alber, H

Early detection of cirrhotic cardiomyopathy using myocardial strain imaging and its correlation to liver stiffness and severity of liver disease – a pilot study

Amrein, K

Osteoporose bei sekundär sklerosierenden Cholangitis nach kritischer Erkrankung

Angermann, H

Risk factors for first intestinal surgery in Crohn's disease

Arasaradnam, RP

Efficacy in Biologic Failure and Nonbiologic-Failure Populations in a Phase 3 Study of Ustekinumab in Moderate-Severe Ulcerative Colitis: UNIFI

Asaturi, A

City or landside area: Do participation rates of quality ensured screening colonoscopy differ?
Influence of moon phases on bowel preparation quality in a screening colonoscopy collective

Asenbaum, U

The value of different CT-based methods for diagnosing sarcopenia and predicting mortality in patients with cirrhosis

Axmann, S

Health Related Quality of Life and Healthcare Resource Utilization in chronic HCV patients under the Glecaprevir/Pibrentasvir Regimen: Interim-Analysis of the Austrian CONFIRMATION Study

Ay, C

Intraperitoneal activation of the coagulation system via tissue factor-exposing extracellular vesicles and enhanced fibrinolysis in patients with advanced chronic liver disease and ascites
The impact of ABO blood type on VWF and factor VIII levels and the prevalence of portal vein thrombosis in patients with advanced chronic liver disease